Astrazen Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.00 M
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.25 Cr
- Revenue Growth 905.50%
- Profit Growth 191.75%
- Ebitda 235.31%
- Net Worth 9.06%
- Total Assets 52.07%
About Astrazen Pharmaceuticals
Astrazen Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 October 2020 (Four years and four months 11 days old ). Its registered office is in Panchkula, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.25 Cr.
Paras Tiwary, Shailja Tiwari, and Nirmal Nirala serve as directors at the Company.
Company Details
- Location
Panchkula, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290HR2020PTC090053
- Company No.
090053
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Oct 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Astrazen Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Paras Tiwary  | Director | 16-Dec-2022 | Current |
| Shailja Tiwari | Director | 14-Mar-2023 | Current |
| Nirmal Nirala | Director | 27-Dec-2023 | Current |
Financial Performance of Astrazen Pharmaceuticals.
Astrazen Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 905.5% increase. The company also saw a substantial improvement in profitability, with a 191.75% increase in profit. The company's net worth moved up by a moderate rise of 9.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Astrazen Pharmaceuticals?
Unlock access to Astrazen Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Excipients Zone LimitedParas Tiwary and Shailja Tiwari are mutual person
Charges (Loans)
₹12.50 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 1.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Apr 2021 | Canara Bank | ₹1.25 Cr | Open |
How Many Employees Work at Astrazen Pharmaceuticals?
Astrazen Pharmaceuticals has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Astrazen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astrazen Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
